Reassignment of the configuration of salvianolic acid B and establishment of its identity with lithospermic acid B

Journal of Natural Products

Volumn 69, Issue 8, 2006, Pages 1231-1233

  Watzke, Anja ^a   O'Malley, Steven J ^a   Bergman, Robert G ^a   Ellman, Jonathan A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHOSPERMIC ACID; NATURAL PRODUCT; SALVIANOLIC ACID B; UNCLASSIFIED DRUG;

ARTICLE; ASIAN; CORRELATION ANALYSIS; DRUG DEGRADATION; DRUG IDENTIFICATION; DRUG STRUCTURE; HERBAL MEDICINE; METHYLATION; NONHUMAN; SALVIA MILTIORRHIZA;

BENZOFURANS; DEPSIDES; MOLECULAR STRUCTURE; PLANTS, MEDICINAL; SALVIA MILTIORRHIZA;

SALVIA MILTIORRHIZA;

EID: 33748796405     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np060136w     Document Type: Article

References (22)

1. Reviews: (a) Jiang, R. W.; Lau, K. M.; Hon, P. M.; Mak, T. C. W.; Woo, K. S.; Fung, K. P. Curr. Med. Chem. 2005, 12, 237-246.
2. (b) Zhou, L.; Zuo, Z.; Chow, M. S. S. J. Clin. Pharmacol. 2005, 45, 1345-1359.
3. (c) Lu, Y. R.; Foo, L. Y. Phytochemistry 2002, 59, 117-140.
4. (a) Chang, H. M.; Cheng, K. P.; Choang, T. F.; Chow, H. F.; Chui, K. Y.; Hon, P. M.; Tan, F. W. L.; Yang, Y.; Zhong, Z. Z.; Lee, C. M.; Sham, M. L.; Chan, C. F.; Cui, Y. X.; Wong, N. H. C. J. Org. Chem. 1990, 55, 3537-3543.
5. (b) Sabri, N. N.; El-Lakany, A. M.; Alexandria. J. Pharm. Sci. 1990, 4, 94-105.
6. (a) Li, X.; Yu, C.; Cai, Y.; Liu, G.; Jia, J.; Wang, Y. J. Chromatogr. B 2005, 820, 41-47.
7. (b) Yokozawa, T.; Liu, Z. W.; Chen, C. P.; Tanaka, T. Pharm. Pharmacol. Commun. 1999, 5, 365-370.
8. Li, L. N. J. Chin. Pharm. Sci. 1997, 6, 57-64.
9. (a) Kong, D. Y. Zhongguo Yiyao Gongye Zazhi 1989, 20, 279-285.
10. (b) Zheng, G. H.; Kakisawa, H. Zhongguo Yaoxue Zazhi 1989, 24, 6-10.
11. (c) Cai, D. G. Zhongguo Zhongyao Zazhi 1991, 16, 376-377.
12. (d) Li, L. N. Zhongguo Yaoxue 1997, 6, 57-64.
13. Ai, C. B.; Li, L. N. J. Nat. Prod. 1988, 51, 145-149.
14. O. K.; Cheung, F.; Sung, F. L.; Zhu, D. Y.; Siow, Y. L. Mol. Cell. Biochem. 2000, 207, 35-39.
15. Hase, K.; Kasimu, R.; Basnet, P.; Kadota, S.; Namba, T. Planta Med. 1997, 63, 22-26.
16. Kamata, K.; lizuka, T.; Nagai, M.; Kasuya, Y. Gen. Pharmacol. 1993, 24, 977-981.
17. Kamata, K.; Noguchi, M.; Nagai, M. Gen. Pharmacol. 1994, 25, 69-73.
18. Abd-Elazem, I.; Chen, H. S.; Bates, R. B.; Huang, R. C. C. Antiviral Res. 2002, 55, 91-1.
19. Tanaka, T.; Morimoto, S.; Nonaka, G.; Nishioka, I.; Yokozawa, T.; Chung, H. Y.; Oura, H. Chem. Pharm. Bull. 1989, 37, 340-344.
20. 2 and Sephadex LH-20 column chromatography (ref 12).
21. O'Malley, S. J.; Tan, K. L.; Watzke, A.; Bergman, R. G.; Ellman, J. A. J. Am. Chem. Soc. 2005, 127, 13496-13497.
22. 6 This comparison of analytical data confirms that the same degradation product, i.e., identical structure and configuration, was obtained in both of our studies.